http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106511297-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5161 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-337 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K9-5146 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-704 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-337 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K9-51 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-40 |
| filingDate | 2016-09-12-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2019-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2019-05-21-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106511297-B |
| titleOfInvention | A kind of doxorubicin nanoparticle with controllable particle size and preparation method thereof |
| abstract | The invention provides a doxorubicin nanoparticle with a controllable particle size. Maleic anhydride) modified β-cyclodextrin is formed by self-assembly encapsulating the inner core. The present invention also provides a preparation method of the doxorubicin nanoparticle. Different from the traditional nanoparticles prepared by the formation and breaking of chemical bonds, the doxorubicin nanoparticles of the present invention have controllable particle size, simple preparation process, mild reaction conditions, easy acquisition of raw materials, and good biological safety and performance. Histocompatibility. |
| priorityDate | 2015-09-10-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 40.